Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy

PURPOSE: To investigate the effect of bevacizumab (Avastin; Genentech, San Francisco, CA, USA) on vascular endothelial growth factor (VEGF) expression and inflammation in fibrovascular membranes in patients with proliferative diabetic retinopathy (PDR). MATERIALS AND METHODS: Fibrovascular membranes...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Eun Jee, Kang, Shin Jeong, Koo, Ja Seung, Choi, Yoon Jung, Grossniklaus, Hans E., Koh, Hyoung Jun
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017691/
https://www.ncbi.nlm.nih.gov/pubmed/21155048
http://dx.doi.org/10.3349/ymj.2011.52.1.151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017691/
https://www.ncbi.nlm.nih.gov/pubmed/21155048
http://dx.doi.org/10.3349/ymj.2011.52.1.151

Ejemplares similares